All products / DC12132
RSV-IN-1
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $950 USDRequest a quote / confirm availability → |
| 250 mg | $1,900 USDRequest a quote / confirm availability → |
| 1 g | $3,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
In Vitro The concentration of P13 that reduces the number of RSV plaques in HEp-2 cells by 50% (IC50) is 0.11 μM. The concentration of P13 that reduces the viability of HEp-2 by 50% (CC50) is 310 μM. Note that some cytotoxicity of P13 observed at 500 μM might be due to DMSO solvent. Hence, the selective index (CC50/IC50) values is 2818 for P13. Note that even at the relatively high concentrations P13 does not completely block the development of RSV plaques. These escape plaques are of smaller size and of non-syncytial phenotype as compared to plaques formed in the absence of inhibitor.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC12132 |
|---|---|
| Product name | RSV-IN-1 |
| CAS | 861139-16-4 |
| Molecular formula | C20H21N5O4S |
| Molecular weight | 427.48 |
| Purity | >98% |
| SMILES | COc1ccc(S(=O)(=O)N(C)CCO)cc1-c1nnc2c3ccccc3c(C)nn12 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — RSV-IN-1 (DC12132)